Avoid common mistakes on your manuscript.
1 Correction to: BioDrugs (2020) 34:245–251 https://doi.org/10.1007/s40259-020-00418-x
The article MYL1501D Insulin Glargine: A Review in Diabetes Mellitus, written by Sheridan M. Hoy, was originally published without Open Access. After publication BGP Products Operations GmbH, Steinhausen, Switzerland requested that the article be Open Choice to make the article an open access publication. Post-publication open access was funded by BGP Products Operations GmbH, Steinhausen, Switzerland. The article is forthwith distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, duplication, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit original author(s) and the source, provide a link to the Creative Commons licence and indicate if changes were made.
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/.
About this article
Cite this article
Hoy, S.M. Correction to: MYL1501D Insulin Glargine: A Review in Diabetes Mellitus. BioDrugs 34, 541 (2020). https://doi.org/10.1007/s40259-020-00426-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40259-020-00426-x